Effect of alirocumab, a monoclonal proprotein convertase subtilisin/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Daniel Gipe Evan A Stein Dean J Kereiakes |
| Publication date | June 18, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |